Estimated Research and Development Investment Needed to Bring a New Medicine to Market, 2009-2018 - Wouters, Olivier J; McKee, Martin; Luyten, Jeroen (JAMA : the journal of the American Medical Association, 2020)
Keywords: Accounting; Chemical compounds; Clinical trials; Clinical Trials as Topic - economics; Costs; Costs and Cost Analysis - statistics & numerical data; Data; Drug Costs; Drug development; Drug Development - economics; Drug Industry - economics; Drug Industry - statistics & numerical data; Drugs; Estimates; Expenditures; FDA approval; Immunomodulators; Investment; Investments; Markets; Medicine; Nervous system; Original Investigation; Pharmaceutical Research - economics; Pharmacology; Public domain; R&D; Regulatory agencies; Research & development; Research & development expenditures; Sensitivity analysis; United States; United States Food and Drug Administration; United States; United States--US